Haemonetics (HAE) Deferred Taxes (2015 - 2026)

Haemonetics' Deferred Taxes history runs 12 years deep, the most recent figure standing at -$20.5 million for Q1 2026.

• In Q1 2026, Deferred Taxes fell 706.19% year-over-year to -$20.5 million; the TTM figure through Mar 2026 stood at -$26.5 million (down 407.2% YoY), while the FY2026 annual figure was -$26.5 million, down 407.2% from the prior year.
• Deferred Taxes was -$20.5 million for Q1 2026 at Haemonetics, down from -$2.1 million in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $3.4 million in Q1 2025 to a low of -$20.5 million in Q1 2026.
• Historically, Deferred Taxes has averaged -$3.1 million across 5 years, with a median of -$2.4 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Deferred Taxes jumped 219.41% in 2022, then plunged 706.19% in 2026.
• A 5-year view of Deferred Taxes shows it stood at $3.0 million in 2022, then slumped by 207.66% to -$3.2 million in 2023, then advanced by 25.52% to -$2.4 million in 2024, then advanced by 14.69% to -$2.1 million in 2025, then slumped by 891.9% to -$20.5 million in 2026.
• The last three Deferred Taxes figures came in at -$20.5 million (Q1 2026), -$2.1 million (Q4 2025), and -$725000.0 (Q3 2025), per Business Quant data.